Isovaleric Acidemia

Related Articles

• Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
• Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
• Smoking May Now Be Considered An Established Risk Factor For ALS, Also Known As Lou Gehrig’s Disease
• Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
• FDA Grants Priority Review for Shire’s velaglucerase alfa for Type 1 Gaucher Disease
• ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
• Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome
• Hyperion Therapeutics Raises $60 Million Series C
• Recent Gene Therapy Advance In Severe Genetic Disorder
• Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

Related Images

• Look for Change Caused by Mass Wasting Since 2007 (PSP_007763_2650)
• Look for Change Caused By Mass Wasting Since 2007 (PSP_009648_2650)
• Filling the Gap
• A Massive Peak
• Smoke and Fires in Eastern Asia

Related Videos

• New Hope for Lou Gehrig's Sufferers
• Skin Peel Syndrome
• Gene May Be Linked to Lou Gehrig's Disease
• MCAD Testing
• New Treatment for Huntington's Disease
• A Pill Can Repair Genetic Defects
• Progress Made Treating Brain Diseases
• Apartment Smoking
• USDA Unveils New Meat Rules
• Racial Bias in Pediatric Emergency Rooms

Related Reference Library

• Munchkin
• Types Of Lightning
• Places To Shelter Yourself From A...
• Tornado Hits Town Northeast Of Tokyo...